Hey Feller, youve been really on the ball with OWCP. And with the new ETF placement, i was wondering of youve taken a look at VDRM. From what i can tell its an enormous licensing play and it is looking like it may takd the path of OWCP.
:) you gotta add pain under the sublingual tablet.. they have snuck that in there lately and that is the biggest mother of them all !!!!!! Pain is the absolute cash maker of everything lumped into 1!!!! It's insanity:) sorry, but that is the most important 1 now!!!! I can't even fathom the market price of it!!! :)
Excellent blog Feller...I have sent it to many via email...some are already invested, others are just plain too stupid to invest in anything other than a mutual fund, but I keep trying to "lead them to water".
Thanks for all you have done for this stock and board.
As usual nice blog FELLER, always pleasure to read. Yep this ticker is ready for multi dollars!! Look no further than CNBX, right now it has MC of $456 million (based on OTC info), its financial shows only total revenue of $112K for the year ended Aug 31, 2016.
Wow!! the ticker, CNBX, has $456 million in MC for $112K revenue!!
Our Psoriasis creme will have lot more revenues than the current revenue for CNBX. PPS could go skyrocketing when the positive efficacy results are released in March. Would not surprise me a bit if OWCP catches up with or exceeds CNBX by then.
I believe the initial euphoria of CNBX came from its initial commercialization of cannabinoids based diagnostics for cancer. So something related to diagnostics while OWCP will have a real products hitting the market in Q2.
Go $$OWCP$$
All imho, not an investment advice. Do your own DD.